Brief: Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri

Processa Pharmaceuticals

19/08/2024 13:08

Aug 19 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL
DATA FOR
NGC-IRI
    * PROCESSA PHARMACEUTICALS INC: STUDIES SUPPORT POTENTIAL
BENEFIT
AS AN IMPROVED TREATMENT WITH FEWER SIDE EFFECTS

Source text for Eikon:  ID:nGNX91vbxR 
Further company coverage:  PCSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))